• 仪器无忧网首页
首页 >  仪器无忧网品牌优搜库 >  Q > 启明创投

中国 . 启明创投

logo

启明创投

Qiming Venture Partners

启明创投 Qiming Venture Partners www.qimingventures.com
启明创投成立于2006年2月,是一家中国领先的风险投资机构,在上海、北京和香港设有办公室。启明创投旗下管理四支基金,资金总额超过11亿美元,专注于媒体和互联网、信息技术、消费者和零售业、医疗保健以及清洁能源等行业早期和成长期企业的投资。
启明创投汇聚了20余位资深职业投资人团队,拥有累计超过100年的企业管理和风险投资经验。启明创投的合伙人都是久负盛名的业界领袖,具有卓越的运营水平和非凡的投资业绩,其中包括在中国和美国成功地运作了一些企业的上市、兼并和收购交易。
启明创投致力于准确捕捉市场机遇,选择能引发新爆发点或被市场低估的企业以及有自主创新技术的高科技企业,着眼于选择执行力强的团队以及具有广阔成长空间的市场。在此理念的支持下,启明创投已投资超过70家企业,帮助众多企业成为了行业当之无愧的领导者,并在业界树立了良好的声誉。在努力成为创业企业的首选投资者的同时,启明创投也与中国其它领先的风险投资公司紧密合作,为年轻的中国企业提供所需要的投资者价值。

启明上海 上海市浦东新区世纪大道88号金茂大厦3901室
邮编:200121; 电话:+86 21 6101 6522; 传真:+86 21 6101 6512
启明香港 香港皇后大道东路太古廣場一座3楼28单元
电话:+852 2855 6848; 传真:+852 2855 6800
启明北京 北京建国门外大街1号中国国际贸易中心24层13-17单元
邮编: 100004; 电话: +86 10 5961 1188; 传真:+86 10 5961 1288

Qiming Venture Partners invests in young, fast-growing companies across China in the media and internet, IT, consumer and retail, healthcare, and clean technology sectors. We’re an early to growth stage venture capital firm with offices in Shanghai, Beijing and Hong Kong. Since our debut in 2006, we’ve established ourselves as a leading investment firm in China and currently manage four funds with over $1.1 billion in assets.
Our team of 20 investment professionals have a wealth of enterprise management and venture capital experience. Our partners are proven business leaders with strong operational experience and successful investment track records, including many successful IPOs and M&A transactions in both the US and China.
We believe in helping companies succeed and committed supporting them as they become sector leaders in China. With a portfolio featuring over 70 investments, Qiming captures market opportunities, choosing promising enterprises with great growth potential, undervalued enterprises, and high-tech enterprises with independent innovation technologies. Our entrepreneurs benefit from access to our portfolio of companies and our global network. While striving to be the investor of choice, Qiming also works closely with other leading venture capital firms in China to deliver the investor value that growing Chinese companies require.